Generally, semaglutide improves blood sugar levels after 2-4 weeks and promotes weight loss after 4-8 weeks of starting the medication
Research has shown that: Weight regain often occurs if semaglutide is discontinued, with most patients regaining two-thirds of their lost weight within a year Long-term use may be necessary for maintaining weight loss, similar to treatments for other chronic conditions Regular monitoring by healthcare providers helps identify and address any concerns Five-year safety data now becoming available continues to support the medications favorable risk-benefit profile The FDA continues post-marketing surveillance of semaglutide to identify any rare adverse events that might not have been detected in clinical trials
F., 3rd
Later, in 2021, Semaglutide was approved under the brand name Wegovy specifically for weight loss
However, key differences lie in their potency, receptor specificity, and additional effects, such as appetite suppression and sexual enhancement
Greater expression of the regional spatial covariance pattern was correlated with greater depressive symptoms [94]
/assets/images/provider/photos/2775923.jpeg)
